Correlation Between Aptose Biosciences and HLS Therapeutics

Can any of the company-specific risk be diversified away by investing in both Aptose Biosciences and HLS Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aptose Biosciences and HLS Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aptose Biosciences and HLS Therapeutics, you can compare the effects of market volatilities on Aptose Biosciences and HLS Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aptose Biosciences with a short position of HLS Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aptose Biosciences and HLS Therapeutics.

Diversification Opportunities for Aptose Biosciences and HLS Therapeutics

0.39

Correlation Coefficient

Aptose Biosciences  HLS Therapeutics

Weak diversification

The 3 months correlation between Aptose and HLS is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Aptose Biosciences and HLS Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HLS Therapeutics and Aptose Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aptose Biosciences are associated (or correlated) with HLS Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HLS Therapeutics has no effect on the direction of Aptose Biosciences i.e., Aptose Biosciences and HLS Therapeutics go up and down completely randomly.

Pair Corralation between Aptose Biosciences and HLS Therapeutics

Assuming the 90 days trading horizon Aptose Biosciences is expected to generate 62.08 times more return on investment than HLS Therapeutics. However, Aptose Biosciences is 62.08 times more volatile than HLS Therapeutics. It trades about 0.12 of its potential returns per unit of risk. HLS Therapeutics is currently generating about 0.15 per unit of risk. If you would invest  36.00  in Aptose Biosciences on December 29, 2024 and sell it today you would earn a total of  445.00  from holding Aptose Biosciences or generate 1236.11% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.44%
Values	Daily Returns

Aptose Biosciences  vs.  HLS Therapeutics

Aptose Biosciences

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Aptose Biosciences are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very fragile basic indicators, Aptose Biosciences displayed solid returns over the last few months and may actually be approaching a breakup point.

HLS Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in HLS Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, HLS Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Aptose Biosciences and HLS Therapeutics

The main advantage of trading using opposite Aptose Biosciences and HLS Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aptose Biosciences position performs unexpectedly, HLS Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HLS Therapeutics will offset losses from the drop in HLS Therapeutics' long position.

The idea behind Aptose Biosciences and HLS Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.